A Vitiligo-like Cutaneous Reaction Induced by Ribociclib in Advanced Breast Cancer: An Unusual Case Report from Colombia
Background: Cutaneous toxicities associated with CDK4/6 inhibitors are uncommon but may affect treatment adherence. We present the case of a patient with advanced breast cancer who developed vitiligo-like lesions after initiating ribociclib, contributing to the growing evidence of this under-recogni...
Saved in:
| Main Authors: | John Fernando Montenegro, Giovanna Patricia Rivas-Tafurt, Sinthia Vidal-Cañas, Miguel Ángel Diaz-Diaz, Cesar Eduardo Bermudez, Daniel Florez, Andres Felipe Bravo-Gustin, Yamil Liscano |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Diseases |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-9721/13/5/158 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ribociclib-induced vitiligo in a case of metastatic carcinoma of the breast
by: Abhira Deb, et al.
Published: (2025-01-01) -
Ribociclib-induced phototoxicity - the era of new drugs and new toxicities
by: Bobić Simonida, et al.
Published: (2024-01-01) -
Medical management of vitiligo: a narrative review
by: Surabhi Sinha, et al.
Published: (2025-01-01) -
Advances in the etiopathogenesis of vitiligo
by: Thomas Mathew, et al.
Published: (2024-12-01) -
Vitiligo en niños: enfoque clínico
by: Claudia Juliana Díaz, et al.
Published: (2018-09-01)